| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 08/08/2006 | US7087630 Cyclooxygenase 2 selective inhibitors, compositions and methods of use |
| 08/08/2006 | US7087628 Heteroaryl and heterocyclic nitrogen ring containing hydrazide compounds useful for treating neurodegenerative disorderes |
| 08/08/2006 | US7087626 TGF-beta signal transduction inhibitors |
| 08/08/2006 | US7087625 N-substituted aniline and diphenylamine analogs |
| 08/08/2006 | US7087624 Substituted pyrazole compounds |
| 08/08/2006 | US7087623 Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof |
| 08/08/2006 | US7087622 Pyridone compounds as inhibitors of bacterial type III protein secreation systems |
| 08/08/2006 | US7087609 3-phenyl-N-{1-[3-(4-pyridin-2-yl-piperazin-1-yl)-phenyl]-ethyl}-acrylamide for example; migraine, neuropathic pain, convulsions, mania, epilepsy, anxiety, depression, bipolar disorder, and neurodegenerative disorders |
| 08/08/2006 | US7087608 Use of PDGF receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy |
| 08/08/2006 | US7087604 Antiarthritic agents;multiple sclerosis; anticholesterol agents; cardiovascular disorders |
| 08/08/2006 | US7087603 Pyrazole compounds useful as protein kinase inhibitors |
| 08/08/2006 | US7087602 Cinnoline derivatives and use as medicine |
| 08/08/2006 | US7087598 Diamide invertebrate pest control agents containing a non-aromatic heterocyclic ring |
| 08/08/2006 | US7087597 Pyrimidine 5-carboxamide compounds, process for producing the same and use thereof |
| 08/08/2006 | US7087593 Psychological disorder treatments that increase the activity of cholinergic receptors |
| 08/08/2006 | CA2282183C Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines |
| 08/08/2006 | CA2253429C 2,4-diaminopyrimidine derivates as dopamine d4 receptor antagonists |
| 08/03/2006 | WO2006081280A1 3-heterocyclyl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immunostimulant activity |
| 08/03/2006 | WO2006081273A1 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroayryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immunostimulant activity |
| 08/03/2006 | WO2006080884A1 Novel biaromatic compounds, inhibitors of the p2x7-receptor |
| 08/03/2006 | WO2006080821A1 Novel benzoimidazole derivatives and pharmaceutical composition comprising the same |
| 08/03/2006 | WO2006080577A1 Indole derivatives |
| 08/03/2006 | WO2006080574A1 1,3-dihydro-2h-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle |
| 08/03/2006 | WO2006080519A1 Diamine derivative |
| 08/03/2006 | WO2006080450A1 Igf-1r inhibitor |
| 08/03/2006 | WO2006080229A1 Organic compound, charge transport material and organic electroluminescent device |
| 08/03/2006 | WO2006079791A1 Chemical compounds |
| 08/03/2006 | WO2006079556A2 Substituted 5-phenyl pyrimidines i in therapy |
| 08/03/2006 | WO2006079549A1 Salts of aripiprazole |
| 08/03/2006 | WO2006065480A3 Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control |
| 08/03/2006 | WO2006065479A3 Substituted phenols as active agents inhibiting vegf production |
| 08/03/2006 | WO2006064375A9 Aminoaryl substituted five-membered ring heterocyclic compounds for the treatment of diseases |
| 08/03/2006 | WO2006063869A3 Symmetrical diazo compounds with 3-pyridinium groups and cationic linker arm, compositions comprising same, dyeing method and device |
| 08/03/2006 | WO2006063867A3 Symmetrical diazo compounds containing 3-pyridinium groups and a non-cationic linker, compositions comrisisng them, method of colouring, and device |
| 08/03/2006 | WO2006055708A3 Heterocycle substituted carboxylic acids for the treatment of diabetes |
| 08/03/2006 | WO2006055503A3 Novel m3 muscarinic acetylcholine receptor antagonists |
| 08/03/2006 | WO2006052264A3 Synthesis, characterization and biological action of optically active isomers of floxacins |
| 08/03/2006 | US20060173182 Process of preparing imatinib and imatinib prepared thereby |
| 08/03/2006 | US20060173158 Reacting sodium salt of aromatic polyols with bis(N-chlorophthalimide)aromatic compound; fine particle size |
| 08/03/2006 | US20060173107 for protecting organic materials, in particular synthetic polymers, against oxidative, thermal, dynamic, light-induced and/or ozone-induced degradation |
| 08/03/2006 | US20060173061 New beta-agonists, processes for preparing them and their use as pharmaceutical compositions |
| 08/03/2006 | US20060173056 Proline derivatives and use thereof as drugs |
| 08/03/2006 | US20060173045 Preventative or remedy for grinding |
| 08/03/2006 | US20060173044 Substituted propargylamines |
| 08/03/2006 | US20060173041 Sulphonylpiperidine derivatives containing an aryl or heteroaryl group for use as matrix metalloproteinase inhibitors |
| 08/03/2006 | US20060173040 bactericide; derivatives of pseudopeptide Andrimid in which beta-phenylalanine amide is replaced by heteroaromatic or substituted aromatic amide; N-{(1S)-3-[((1S)-1-{[(3R,4S)-1,4-Dimethyl-2,5-dioxo-3-pyrrolidinyl]carbonyl}-2-methylpropyl)amino]-3-oxo-1-phenylpropyl}-2-pyridinecarboxamide; antibiotics |
| 08/03/2006 | US20060173039 Excellent poly (ADP-ribose) synthetase inhibitors; various ischemic diseases, inflammatory diseases, neurodegenerative diseases, diabetes, septic shock, cephalic injury; 1,2-Dihydro-4-[4-(dimethylaminomethyl)phenyl]-5-hydroxy-1-oxoisoquinoline |
| 08/03/2006 | US20060173034 Novel 4-anilinoquinoline-3-carboxamides |
| 08/03/2006 | US20060173027 Spirocvclic piperidines as mch1 antagonists and uses thereof |
| 08/03/2006 | US20060173024 Compositions and methods for treating heart failure |
| 08/03/2006 | US20060173022 Heterocyclic amides, method for the production thereof, substances containing said heterocyclic amides, and use thereof as pesticides |
| 08/03/2006 | US20060173019 Heteroaryl sulfonamides and CCR2 |
| 08/03/2006 | US20060173014 Useful for the prevention and/or treatment of cognitive disorders; 3-Amino-N-(3-nitrophenyl)-6-[4-(pyrrolidin-1-ylsulfonyl)phenyl]pyrazine-2-carboxamide, for example |
| 08/03/2006 | US20060173013 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity |
| 08/03/2006 | US20060173010 Modulators of TNF-alpha signaling |
| 08/03/2006 | US20060173008 New pyridazin-3(2h)-one derivatives |
| 08/03/2006 | US20060173003 4-Heteroarylamino-7-H(hetero)aryl-substituted, e.g., [6-(propane-2-sulfonyl)-pyridin-3-yl]-[7-(3-trifluoromethyl-pyridin-2-yl)-quinazolin-4-yl ]-amine hydrochloride; the compounds inhibit binding of vanilloid ligands to capsaicin receptors and are used to treat neuropathic pain |
| 08/03/2006 | US20060172988 Azetidine compounds |
| 08/03/2006 | US20060172984 Methods and compositions of novel triazine compounds |
| 08/03/2006 | US20060172971 e.g. 2-[(2-bromo-4-fluoro-phenyl)-hydrazono]-propionic acid ethyl ester; protein tyrosine kinase inhibitor, but does not inhibit ATP binding to the protein tyrosine kinase; and as anticarcinogenic agent, psoriasis, atherosclerosis, or immune system activity |
| 08/03/2006 | US20060172950 Hepatitis C virus inhibitors |
| 08/03/2006 | CA2596527A1 Igf-1r inhibitors |
| 08/03/2006 | CA2596237A1 Diamine derivative |
| 08/03/2006 | CA2595958A1 Substituted 5-phenyl pyrimidines i in therapy |
| 08/03/2006 | CA2595855A1 Pyrazine compounds for inflammation and immune-related uses |
| 08/03/2006 | CA2595522A1 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity |
| 08/03/2006 | CA2595218A1 Indole derivatives having inhibitory activity against sodium-dependent glucose transporter |
| 08/03/2006 | CA2594708A1 Chemical compounds |
| 08/03/2006 | CA2594690A1 Salts of aripiprazole |
| 08/02/2006 | EP1686127A1 New heterocyclylmethyl-substituted pyrazole derivatives and their use for treating cardiovascular diseases |
| 08/02/2006 | EP1686126A1 Salts of aripiprazole |
| 08/02/2006 | EP1686120A2 Methods and compositions utilizing quinazolinones |
| 08/02/2006 | EP1686119A1 Pyrimidine-4-one derivatives as ldl-pla2 inhibitors |
| 08/02/2006 | EP1685138A1 Regiospecific synthesis of nicotine derivatives |
| 08/02/2006 | EP1685125A1 Pyrrol derivatives |
| 08/02/2006 | EP1685124A1 Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain |
| 08/02/2006 | EP1685123A2 Substituted dihydroquinazolines ii |
| 08/02/2006 | EP1685119A1 N-acylsulfonamide apoptosis promoters |
| 08/02/2006 | EP1685116A1 Quinazoline derivatives |
| 08/02/2006 | EP1685115A1 Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders |
| 08/02/2006 | EP1685113A1 Substituted pyrazoles as ppar agonists |
| 08/02/2006 | EP1685111A1 Substituted nicotinoylcarbamates as pesticides |
| 08/02/2006 | EP1685109A2 Amide compounds as ion channel ligands and uses thereof |
| 08/02/2006 | EP1685105A1 Allosteric modulators of metabotropic glutamate receptors |
| 08/02/2006 | EP1685102A1 Melanocortin receptor agonists |
| 08/02/2006 | EP1685101A1 N-acylated-3-(benzoyl)-pyrrolidines as 11-beta-hsd1 inhibitors useful for the treatment of metabolic disorders. |
| 08/02/2006 | EP1685100A1 Novel 1, 3-disubstituted azetidine derivatives for use as 5ht2a receptor ligands |
| 08/02/2006 | EP1685090A1 Androgen receptor modulators |
| 08/02/2006 | EP1684757A1 Substituted piperidines for the treatment of metabolic syndrome |
| 08/02/2006 | EP1684754A1 Hmg-coa reductase inhibitors and method |
| 08/02/2006 | EP1684745A2 Hepatitis c virus inhibitors |
| 08/02/2006 | EP1684744A2 Pyrrolidine and piperidine derivatives as factor xa inhibitors |
| 08/02/2006 | EP1684694A2 Akt protein kinase inhibitors |
| 08/02/2006 | EP1529043B1 Process for the preparation of 2-methyl piperazine derivatives. |
| 08/02/2006 | EP1434766B1 Piperidine compounds as muscarinic antagonists |
| 08/02/2006 | EP1358177B1 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 08/02/2006 | EP1274692B1 Quinazoline compounds |
| 08/02/2006 | EP1076057B1 Febrifugine and isofebrifugine and processes for the preparation of both |
| 08/02/2006 | EP1073637B1 3-(amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of hiv related diseases |
| 08/02/2006 | EP1030662B1 Treatment of t-helper cell type 2 mediated immune diseases with retinoid antagonists |